This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Effectiveness: Mental Health
Importance and Measures
Prevalence and Incidence
- Depression affects about 9.5% of Americans'19 million people—in a given year1.
Morbidity and Mortality
- About 60% of people who commit suicide have had a mood disorder, including major depression, bipolar disorder, or dysthymia2.
- The World Health Organization estimates that depression will be the second leading cause of disability worldwide by 20203.
- The financial costs of depression among the working population are estimated at over $43 billion per year4.
The NHQR tracks four measures for clinical depression, including two measures of appropriate antidepressant medication treatment, one measure of practitioner contacti, and the national suicide rate. This section highlights both measures of medication treatment quality for adults:
- Receipt of antidepressant medication treatment during acute phase (i.e., first 3 months following initial diagnosis)
- Receipt of antidepressant medication treatment through continuation phase (6 months) of treatment
iThis report does not focus on optimal practitioner contacts for medication management because the measure specifications are changing this year.